News
Cardinal Health (NYSE: CAH) today announced that The Specialty Alliance, its multi-specialty management services organization ...
Cardinal Health will acquire Solaris Health for $1.9 billion, lifting its specialty platform while posting mixed Q4 results ...
The healthcare conglomerate handily beat on the bottom line in its latest reported quarter, but that's not what the market was paying attention to.
Cardinal Health, Inc. is rated a Buy with a $239 fair value, driven by specialty growth in autoimmune, urology & oncology.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results